Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Merck and Company, Inc. | Merck | pharmaceuticals | labor relations violation | 2009 | NLRB | $10,710 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
Immunex Corp. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Johnson and Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | WV-AG | $4,475,000 |
Merck & Co. Inc. | Merck | pharmaceuticals | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |
Merck KGaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $400,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
Shering-Plough/Warrick Companies | Merck | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Synthes, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | NJ-AG | $236,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Warrick Pharmaceuticals Inc. | Merck | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2009 | PA-ENV | $15,720 |
IDEXX Reference Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | environmental violation | 2009 | AZ-DEQ | $80,000 |
PHARMACIA CORPORATION, et al. | Pfizer | pharmaceuticals | environmental violation | 2009 | IL-ENV | $96,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | NC-ENV | $36,836 |
ETHICON INC | Johnson & Johnson | pharmaceuticals | air pollution violation | 2009 | NJ-ENV | $5,250 |
MERCK SHARP & DOHME CORP - RAHWAY NJ | Merck | pharmaceuticals | air pollution violation | 2009 | NJ-ENV | $8,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2009 | NJ-ENV | $8,900 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2009 | NJ-ENV | $10,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $10,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $55,000,000 |
PFIZER, INC. | Pfizer | pharmaceuticals | workplace safety or health violation | 2009 | OSHA | $7,155 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | $19,538 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
E.R. Squibb & Sons LLC | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2009 | EPA | $8,125 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | EPA | $26,797 |
ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | air pollution violation | 2009 | EPA | $12,000 |
Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | pharmaceuticals | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $15,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Purepac Pharmaceutical Co. | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,650,000 |